AEterna Zentaris Inc. diskutieren
AEterna Zentaris Inc.
WKN: A3DMG4 / Symbol: AEZS / Name: AEterna Zentaris / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
1,87 €
-3,13 %
Buy AEterna Zentaris Inc.
Sell AEterna Zentaris Inc.
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) had its price target lowered by analysts at HC Wainwright from $28.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Aeterna Zentaris Inc. (NASDAQ: AEZS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for AEZS provided by MarketBeat
Neueste Beiträge
BTIG_Research in Galmed Pharmaceuticals Ltd. diskutieren